Medicare Trustees Report 2026: HI Fund Depletion Moves to 2033, Actuarial Deficit Widens 33 Percent

The 2026 Medicare Trustees Report, released in spring 2026, projects Hospital Insurance trust fund depletion in the second quarter of 2033, one quarter earlier than last year's estimate. The 75-year actuarial deficit widened to 0.56% of taxable payroll, up from 0.42% in the 2025 report, a 33% single-year deterioration in the measure health actuaries use to assess Medicare's structural funding gap. Closing that gap starting in January 2026 would have required either a 12% immediate reduction in scheduled HI benefits or a Medicare payroll tax increase from 2.90% to 3.46%. Neither has been enacted. These are not abstract fiscal projections. They are the government's official actuarial accounting of whether the benefits scheduled for current and future beneficiaries can be paid, and the 2026 numbers move in the wrong direction on every headline measure.

Working through the Trustees Report technical supplement across multiple publication years, the 75-year closed-group actuarial balance moves slowly enough that a 33% single-year jump in the shortfall, from 0.42% to 0.56% of taxable payroll, is a meaningful signal of underlying assumptions worsening rather than just a rounding artifact or demographic shift already priced into the prior forecast. The 0.14 percentage point increase is substantial by the standards of this measure's historical year-to-year movement, and understanding what drove it matters for health actuaries who use the Trustees Report as a long-term forecasting anchor for benefit design assumptions and plan financial modeling.

What Changed Between the 2025 and 2026 Reports

The 2026 deterioration reflects a combination of factors the Trustees itemize in the report's technical supplement: higher projected costs for Medicare Advantage plans, certain provider payment adjustments, and the enactment of federal legislation in 2026 that altered the program's cost and revenue trajectory. The One Big Beautiful Bill Act, passed in 2026, incorporated provisions the trustees' modeling now reflects in the updated HI deficit numbers. Any further legislative action, particularly Medicaid restructuring that shifts cost-sharing or affects dual-eligible populations, may produce secondary effects on Medicare utilization requiring a mid-cycle assumption review in plans that rely on 2026 Trustees projections as baseline inputs.

The shift in the depletion date from the third quarter to the second quarter of 2033 is one quarter. That single quarter matters less as a precision forecast than as a directional signal. The prior year's report was itself earlier than the year before, and the structural mechanism driving the date forward has not changed: HI income, primarily the 2.90% payroll tax plus a portion of income taxes on Social Security benefits, is growing more slowly than HI expenditures. The 2026 report projects annual HI deficits as a share of taxable payroll at 0.45% in 2033, climbing to 0.71% at the 2043 peak before moderating to 0.35% by 2100 under the baseline scenario. The 2043 peak corresponds to the period when the full baby boom cohort will be in the Medicare system, and actuaries building 20-year financial models should treat that decade as the most actuarially demanding near-term horizon in Medicare's funding history.

The Mechanics of What Depletion Actually Means

When the HI trust fund reaches zero, the law's automatic mechanism takes effect: the fund cannot pay more than it receives in current period income. At depletion in 2033, today's 58-year-olds will become Medicare-eligible for the first time. Income at that moment would cover approximately 89% of scheduled HI costs, meaning an 11% automatic reduction in payments to hospitals, skilled nursing facilities, home health agencies, and hospice providers takes effect without any Congressional action required. That payment reduction grows to 16% by 2040 as the structural imbalance widens.

The 11% figure requires context for actuaries who work primarily in the pricing or reserving function. Hospital contracts with Medicare operate on DRG-based payment rates that are not administratively flexible in the short term. A sudden 11% payment reduction is not absorbed by hospital efficiency gains or overhead adjustments; it is a reduction in the actual dollar payment for each DRG. Providers operating on tight Medicare margins, particularly rural hospitals and safety-net facilities, would face immediate financial distress. That provider stress, in turn, creates access and network adequacy issues for Medicare Advantage plans whose contract networks depend on those providers accepting MA patients at rates pegged to Medicare FFS.

The scenario also matters for stop-loss carriers and self-insured employer plan sponsors. Medicare Secondary Payer rules make Medicare the primary payer for most retirees on employer-sponsored plans and the secondary payer for active employees at large group employers. Stop-loss attachment points calibrated against actuarial assumptions that include Medicare's current FFS payment levels are exposed to the same benchmark dynamics that affect MA pricing, through a different mechanism: the secondary payer calculation changes when Medicare's share of any bill changes. Stop-loss actuaries currently have no standardized methodology for loading the probability of a depletion-triggered payment reduction event into their pricing models, and with the 2033 date now seven years out, that risk sits within the multi-year financial planning horizon for carriers writing five-year stop-loss blocks.

Reading the CMS Chief Actuary's Alternative Scenario

The annual alternative scenario memorandum from the CMS Office of the Actuary deserves as much attention from health actuaries as the Trustees' baseline projection, because the baseline depends on assumptions that the Chief Actuary's office has described as optimistic in material respects. The alternative scenario in the 2026 report produces a 75-year HI shortfall of 1.38% of taxable payroll, versus 0.56% in the baseline. Total Medicare spending under the alternative scenario reaches 9.8% of GDP by 2100, compared to 7.5% of GDP under the baseline. The difference between these two trajectories, compounded across 75 years, represents a divergence in cumulative program costs that is far larger in absolute terms than any single legislative adjustment currently under political discussion.

The primary driver of the divergence is the productivity adjustment. Current Medicare law requires annual reductions in Medicare payment rate growth tied to economy-wide productivity gains. The baseline assumes these reductions execute as written through the entire projection period. The Chief Actuary's alternative scenario phases the productivity adjustments down gradually starting in 2028, consistent with the historical pattern in which Congress has reliably found ways to modify or override scheduled Medicare payment cuts when they approach implementation. The most prominent example is the Sustainable Growth Rate formula, which Congress overrode annually for 17 years before replacing it with MACRA in 2015, absorbing roughly $170 billion in costs above what the SGR formula would have required.

The Actuarial Implication of the Two Scenarios

A baseline scenario that assumes politically difficult productivity adjustments will execute as scheduled across multiple presidential and congressional cycles is a baseline with known optimism embedded. The alternative scenario is not labeled "pessimistic." It is labeled "alternative" because it reflects what the Chief Actuary's office judges to be a reasonable illustration of outcomes if productivity adjustment execution follows historical congressional behavior rather than the statutory schedule. For actuaries building long-term financial models with Medicare as a cost benchmark, using only the baseline as an anchor understates the range of plausible futures by a meaningful margin.

SMI Structure: Part B and Part D Are Different, but Not Immune

Medicare's Supplementary Medical Insurance program, covering Part B physician and outpatient services and Part D prescription drug coverage, operates on a fundamentally different financing structure than HI. Part B and Part D are funded by a combination of participant premiums, currently set to cover 25% of program costs, and federal general revenues covering the remaining 75%. Because SMI is not dependent on a dedicated trust fund with a fixed balance, it carries no depletion date comparable to the 2033 HI projection. CMS projects that the SMI funds are adequately financed over the Trustees' projection period. That assessment, however, rests on the structural reality that SMI funds have the legal authority to draw whatever general revenues are needed, not because SMI cost growth is on a sustainable trajectory.

Part B spending as a share of GDP is projected to grow from 2.0% in 2026 to 3.7% by 2050 and 4.5% by 2100 under the baseline scenario. Under the alternative scenario, Part B reaches 5.7% of GDP by 2100. Total Medicare expenditures including Parts A, B, and D are projected at 4.1% of GDP in 2026, growing to 6.5% by 2050 and 7.5% by 2100. The 2026 Trustees Report notes that Medicare expenditures are projected to grow faster than both aggregate wages and the broader economy, a structural driver that no near-term correction in MA star ratings, FFS payment policy, or prescription drug price negotiation can offset without legislative action targeting the program's fundamental financing structure.

For health actuaries working on employer plan design or long-term healthcare cost projections, the SMI trajectory carries a different but equally important signal. The 25% premium funding mechanism means Part B premiums must rise continuously to track cost growth. The Part D redesign implemented in 2026, which substantially restructured catastrophic coverage liability between the federal government, plans, and manufacturers, created a new actuarial challenge: premium stability commitments in a program where the government's subsidy share is structurally fixed at 75% regardless of how costs move. The interaction between the Part D 2026 redesign's first-year data and the Trustees' longer-run cost projections is one of the more technically complex forecasting questions in health actuarial practice right now.

Medicare Advantage's Position in the Part A Trust Fund

Medicare Advantage now covers 51% of all Medicare beneficiaries, a program scale that has compressed traditional FFS Medicare to the minority enrollment position for the first time in the program's modern history. The 2026 Trustees project that MA share rising to 56% by 2035, though the report also flags a dramatic slowing in the annual rate of FFS-to-MA migration, from the 1% to 5% per year transfer that characterized the past decade down to less than 1% per year from 2026 to 2035.

One finding embedded in the 2026 report deserves direct attention from anyone pricing or modeling MA plan finances: MA-related expenditures within the Part A trust fund are projected to exceed FFS Medicare expenditures within that fund by 2028. That crossover reflects the enrollment transformation that has already occurred and creates a structural dynamic with no historical precedent in how the fund was designed. The Part A trust fund was architected around a predominantly FFS Medicare population. When MA payment flows from Part A outweigh FFS payment flows, the fund's income and outgo profile shifts in ways that complicate the standard assumption that MA plan growth is a more efficient use of trust fund resources than FFS.

The picture on Medicare Advantage plan exits and forced disenrollment from the current contract year already demonstrates how quickly the enrollment assumptions underlying MA financial models can shift. Three million beneficiaries facing forced disenrollment in 2026 is not a marginal operational event; it is a signal that the MA market's prior growth assumptions are being recalibrated under financial pressure from every direction simultaneously: V28 risk adjustment, benchmark compression from prior advance notice cycles, and now the structural FFS baseline uncertainty the Trustees Report documents.

MA Plan Actuaries and the 2027 Bid Implications

CMS sets Medicare Advantage benchmarks as a percentage of projected per-capita FFS Medicare spending in each county, adjusted for demographic and risk factors. The benchmark is the ceiling on what CMS will pay a plan, and plan bids below benchmark generate rebate dollars that plans use to fund supplemental benefits. The entire MA pricing mechanism, from bid development through benefit design through multi-year margin projection, is calibrated against a FFS Medicare spending baseline that itself now carries explicit solvency risk.

When HI trust fund pressure translates into legislative action, the typical Congressional toolkit involves some combination of provider payment rate modifications, eligibility adjustments, and cost-sharing restructuring. Provider payment rate reductions directly compress the FFS spending that county benchmarks reflect. A 5% across-the-board reduction in Medicare inpatient payment rates would reduce benchmarks in every county before plan actuaries can revise their bids for the affected contract year. Plans that entered a contract year with bids close to benchmark would absorb a revenue reduction with no mechanism for in-year adjustment outside of the filing cycle.

The CMS 2027 Medicare Advantage rate reversal and its actuarial implications already forced plan pricing teams to model compressed margin scenarios. The 2026 Trustees Report adds a longer-run layer to that near-term pressure: the FFS baseline against which 2028, 2029, and 2030 benchmarks will be set is governed by a system under fiscal strain. Actuaries building multi-year financial projections for MA plans should scenario-test against a world in which HI pressure accelerates benchmark compression beyond the organic trend reductions CMS has implemented in recent advance notice cycles.

A Note on the KFF Paradox Framing

The KFF Medicare Advantage benefits and premiums paradox documented in 2026 showed how MA plans simultaneously reduced supplemental benefits and maintained low premiums, defying the intuitive expectation that benefit reductions would translate into premium savings. The Trustees Report adds a structural explanation for why that paradox persists: MA plans are managing margin recovery under benchmark compression, and the benefit reduction is the primary adjustment mechanism available inside the bid structure. If benchmark compression accelerates under HI fund pressure, that margin management dynamic intensifies, not relaxes.

What the Legislative Path Would Actually Require

The 2026 Trustees Report restates, with actuarial precision, how large the corrective action would need to be. Starting in January 2026, restoring 75-year HI solvency under the baseline scenario would have required either a 12% immediate and permanent reduction in all scheduled HI benefits or an immediate and permanent increase in the Medicare payroll tax from 2.90% to 3.46%, an increase of 0.56 percentage points applied equally to employees and employers. Waiting to act until depletion is imminent makes both options larger, not smaller: the mathematical reality of deferred corrections in a compounding system is that delay costs more in total adjustment required.

Under the CMS Chief Actuary's alternative scenario, the required corrections are substantially larger: a payroll tax increase of 1.4 percentage points (from 2.90% to approximately 4.30%, roughly a 50% rate increase) or a spending reduction of approximately 25% from scheduled benefit levels. Those numbers are not the policy recommendation; they are the actuarial arithmetic of what would close the gap if the alternative scenario's assumptions prove correct. The Committee for a Responsible Federal Budget's 2026 analysis of the Trustees Report puts the alternative scenario shortfall at 1.38% of taxable payroll versus the 0.56% baseline, a gap that reflects decades of compounding difference between the two assumptions about productivity adjustment execution.

No legislative fix is on a credible near-term path. The bipartisan consensus that produced the 1983 Social Security amendments, which combined a gradual increase in the full retirement age, benefit adjustments, and a payroll tax rate increase to restore solvency for a generation, has not formed around Medicare's structural financing challenge. The trustees have quantified the shortfall with increasing precision every year. The legislative response has been silence on the structural question, punctuated by targeted payment policy changes that address near-term budget arithmetic without altering the long-run actuarial balance.

For actuaries advising clients on long-term benefit design or pension plan medical benefit liabilities, the political trajectory of the HI trust fund has a direct valuation implication. A defined benefit plan sponsor offering retiree medical benefits with Medicare as the coordination-of-benefits primary payer for retirees over 65 is implicitly assuming that Medicare continues to pay its scheduled share. If the planning period extends past 2033, that assumption deserves explicit scenario analysis, not a single-point baseline treatment.

Tracking the Signal Forward

The 2026 Trustees Report's most important contribution for health actuaries is not the specific 2033 depletion date, which will shift again in the 2027 report, but the combination of two signals that together deserve more attention than trade press coverage of the annual report typically gives them. First, the 75-year actuarial deficit moved 33% in a single year, from 0.42% to 0.56% of payroll. Single-year deterioration at that rate in the structural solvency measure indicates that the underlying demographic and cost assumptions are worsening, not just tracking the prior-year forecast with minor updates. Second, the CMS Chief Actuary's alternative scenario, at 1.38% of payroll shortfall versus the 0.56% baseline, is not a tail risk scenario; it is the Chief Actuary's judgment about what Medicare's cost path looks like if productivity adjustments behave consistently with historical congressional action rather than with statutory language. The gap between 0.56% and 1.38% is the range of professional actuarial judgment about how to model political execution risk across a 75-year horizon.

For MA plan actuaries building 2027 bids against a Medicare FFS baseline, the near-term monitoring list is concrete. Watch whether the 2027 advance notice cycle brings further benchmark compression driven by FFS cost reduction policies tied to HI trust fund politics. Watch whether the legislative environment around OBBBA produces secondary effects on Medicare Advantage or Medicaid coordination that alter the utilization assumptions feeding into bid development. Watch the annual HI income and outgo statements as the fund balance draws down: the speed of draw-down in the years immediately preceding a projected depletion date tells actuaries whether the depletion date is stable or accelerating, and that difference matters for how much buffer to build into multi-year financial projections priced against benchmarks that could compress sharply in response to Congressional action in the 2028-to-2031 window.

The comprehensive Medicare Advantage actuarial guide for 2026 covers the V28 risk adjustment, forced disenrollment, and benefit dynamics that define the near-term MA pricing environment. The Trustees Report adds the structural layer: the FFS baseline that MA benchmark arithmetic depends on is itself on a documented solvency clock. Actuaries who price MA products without explicitly scenario-testing the benchmark against a range of HI trust fund outcomes are anchoring their projections to a baseline that carries uncertainty the Trustees have now quantified, and quantified as worsening.